Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... with an antiserum against LV or a combination of the antiviral drugs Pleconaril and Ribavirin. In the group treated with antiviral drugs, the onset was significantly delayed," wrote ...
2009 NOV 16 ... study of two direct-acting antiviral (DAA) compounds administered without interferon or ribavirin for the treatment of patients chronically infected with the hepatitis C virus (HCV).(i) ...
2009 NOV 16 ... with either peg-IFN-alfa-2a (PEGASYS®) or peg-IFN-alfa-2b (PEGINTRON®) and ribavirin (RBV), for 12 weeks followed by an additional 12 weeks of peg-IFN and RBV in a ...
2009 NOV 16 ... was associated with HCV infection. In addition, treatment with pegylated interferon and ribavirin, initiated within 6 months of diagnosis, was completed in 16 patients with genotype 1 ...
2009 NOV 23 ... virological response rates in Phase III randomized trials, pegylated IFN coupled with ribavirin has become the standard of care for chronic hepatitis C. Currently, two forms of ...
2009 NOV 23 ... the case of a 30-year-old man with hepatitis C infection treated with IFN-alpha and ribavirin who developed acute psychosis with persecutory delusions and auditory hallucinations, ...
2009 NOV 16 ... of the approved anti-influenza drugs oseltamivir and amantadine together with ribavirin against three influenza virus strains using cytopathic effect inhibition assays in MDCK ...
2009 NOV 23 ... chronic HCV consists of a combination of PEGylated interferon-alpha (PEG-IFN-alpha) and ribavirin (RBV)," scientists writing in the journal Nature Genetics report. "To ...
2009 NOV 16 ... Impression Scale 6 months after the end of antiviral treatment with IFN-alpha and ribavirin. Six months after antiviral therapy, 49% of the patients showed a worsening and 27.2% an ...
2009 NOV 16 ... received a 4-week lead-in of PEGINTRON® (peginterferon alfa-2b) and REBETOL® (ribavirin, USP) followed by the addition of narlaprevir, 85-87 percent of patients achieved rapid ...
2009 NOV 23 ... for patients with chronic hepatitis C, pegylated interferon-alpha (PEG-IFN-alpha) plus ribavirin (RBV), does not provide sustained virologic response (SVR) in all patients. We report a ...
2009 NOV 16 ... randomized 1:1 to 360 mu g (n = 448) or 180 mu g (n = 448) PEG-IFN alpha-2a weekly plus ribavirin at 1000-1200 mg/day for 12 weeks, followed by 36 weeks of 180 mu g PEG-IFN alpha-2a ...
2009 NOV 16 ... with chronic hepatitis C have not responded to therapy with pegylated interferon plus ribavirin. To evaluate use of peginterferon-alpha 2a plus...
2009 NOV 16 ... most of the hepatitis C virus (HCV)-infected patients that receive it. The addition of ribavirin to IFN therapy has increased the response rate dramatically," scientists in the United ...
2009 NOV 16 ... testing, the triple combination of oseltamivir (Tamiflu), amantadine (Symmetrel) and ribavirin showed a significant capacity to stop flu-virus growth, says Mark Prichard, Ph.D, who ...
2009 NOV 16 ... PEGINTRON is indicated in the U.S. for use in combination with REBETOL=AE (ribavirin) for the treatment of chronic hepatitis C in patients 3 years of age and older with ...
2009 NOV 16 ... analysis for its Phase IIb dose-finding clinical trial for taribavirin, a prodrug of ribavirin which is in development for the treatment of chronic hepatitis C in conjunction with a ...
2009 NOV 16 ... dose-ranging clinical trial evaluated PEG-Interferon lambda as a single agent and with ribavirin in relapsed and treatment naive patients with hepatitis C. The results indicated that ...
